glp 1 with kidney disease New Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs GLP-1 and the kidney: from

(12) These challenges lengthen hospital stays, increase the need for readmissions or revision procedures, and impair long-term functional outcomes

370, no

Semaglutide also influences gut hormones that regulate blood sugar and energy use, creating a cascade of metabolic adjustments

This route however appears to be largely ignored and probably will continue to be ignored, since the strategy so far has been to simply create agonists which are structurally designed to be resistant to DPP-4 (In fact, most modifications to extend the half-life of GLP1R/GIPR/GR agonists so far, do so by making the drugs resistant to DPP-4 )

Instead, reducing the frequency of dosing to lower doses is the best way to maintain results and reduce the financial burden of treatment, Finn said